| STUDY | ACCR. GOAL |
R E G |
O P E N |
ARM | TOTAL REGS. |
REGS. LAST 12 Month |
REGS. LAST 6 Month |
REGS. LAST 3 Month |
REGS. LAST 30 DAYS |
REGS. LAST 7 DAYS |
DATE OF FIRST REG. |
# of ACT. INSTs |
# of CURR IRBs |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| S1703-Met Breast, STM-monitoring v Usual Care | 498 | 2 | Y | 1 Control (Usual Care) | 234 | 26 | 11 | 6 | 1 | 0 | 09/17/2018 | 247 | 92 |
| 2 Intervention (STMDDM) | 239 | 26 | 10 | 7 | 0 | 0 | 09/17/2018 | 247 | 92 | ||||
| 473 | 52 | 21 | 13 | 1 | 0 | ||||||||
| S2417CD-Colrec Surv, Follow-up w/ CTAC site | 654 | 1 | Y | 1 CTAC Intervention | 82 | 82 | 56 | 31 | 12 | 1 | 10/15/2025 | 159 | 45 |
| 2 CTAC Control | 42 | 42 | 25 | 11 | 2 | 0 | 10/15/2025 | 159 | 45 | ||||
| 124 | 124 | 81 | 42 | 14 | 1 | ||||||||
| S2424CD-A-PACT vs SOC for GOC communication | 1000 | 1 | Y | Blinded Drug | 1 | 1 | 1 | 1 | 0 | 0 | 08/07/2026 | 38 | 7 |
| 1 | 1 | 1 | 1 | 0 | 0 | ||||||||
| A231602C-Blood Cancer, Assess Financial Difficulty | 1 | T | 4 | 0 | 0 | 0 | 0 | 0 | 06/04/2020 | ||||
| 4 | 0 | 0 | 0 | 0 | 0 | ||||||||
| ACCL16N1-Guideline Consistent Treatment AYA ALL | 1 | T | 54 | 0 | 0 | 0 | 0 | 0 | 10/24/2018 | ||||
| 54 | 0 | 0 | 0 | 0 | 0 | ||||||||